Skip to content
CMS overreach will impede innovation
In implementing the Inflation Reduction Act (IRA), the Centers for Medicare and Medicaid Services (CMS) has made efforts to unnecessarily broaden the law with […]
CMS overreach will impede innovation Read More »
Latest News
FDA approves Merck’s vaccine against pneumococcus bacteria
The U.S. Food and Drug Administration (FDA) approved the CAPVAXIVE™ vaccine to protect adults from bacteria that can cause pneumonia and invasive pneumococcal disease
FDA approves Merck’s vaccine against pneumococcus bacteria Read More »
BIO 2024: Can data improve clinical trial diversity?
The COVID pandemic underscored the reality of medical inequity worldwide, a longstanding issue reflected in clinical trials, particularly regarding the absence of race and
BIO 2024: Can data improve clinical trial diversity? Read More »
7% of U.S. adults had long COVID, find new studies
About 7% of all U.S. adults have experienced long COVID, according to new studies seeking to identify the scope of the problem and define
7% of U.S. adults had long COVID, find new studies Read More »
BIO 2024: What patient advocates said about AFPs, Medicare Part D, and more
In 2024, the BIO International Convention is shining a bright light on patients—in line with one of the Biotechnology Innovation Organization’s strategic priorities to
BIO 2024: What patient advocates said about AFPs, Medicare Part D, and more Read More »
BIO 2024: Education can improve regulation, biotech innovators say
With rapid innovations in agriculture, energy, and environmental biotech, the industry must try to educate regulators and the public about the latest scientific advances
BIO 2024: Education can improve regulation, biotech innovators say Read More »
BIO 2024: Investing in women’s health is an untapped gold mine
Investing in women’s health is a gold mine that few healthcare investors have yet to tap, according to a new study that has come
BIO 2024: Investing in women’s health is an untapped gold mine Read More »
We can eliminate cervical cancer in our lifetime – here’s how
In August 2020, the World Health Organization (WHO) adopted a global strategy to eliminate cervical cancer in our lifetime. “To eliminate cervical cancer,” according
We can eliminate cervical cancer in our lifetime – here’s how Read More »
FDA approves Arexvy for patients 50–59
On June 7, the U.S. Food and Drug Administration (FDA) approved an expanded age indication for GSK’s Arexvy, making it the first respiratory syncytial
FDA approves Arexvy for patients 50–59 Read More »
BIO 2024: PDABs and IRA pose a murky threat to patient access
With the passage of the Inflation Reduction Act (IRA) and the growing number of prescription drug affordability boards (PDABs), patients and the biotech industry
BIO 2024: PDABs and IRA pose a murky threat to patient access Read More »